{"doi":"10.2471\/BLT.07.048694","coreId":"220344","oai":"oai:eprints.lse.ac.uk:37717","identifiers":["oai:eprints.lse.ac.uk:37717","10.2471\/BLT.07.048694"],"title":"Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso","authors":["Toure, Seydou","Zhang, Y.","Bosque-Oliva, Elisa","Ky, Cesaire","Ouedraogo, Amadou","Koukounari, Artemis","Gabrielli, Albis F","Sellin, Bertrand","Webster, Joanne P.","Fenwick, Alan"],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2008-10","abstract":"Objective\\ud\n\\ud\nTo evaluate the impact on schistosomiasis of biennial treatment with praziquantel (PZQ) among school-age children in Burkina Faso, the first country that achieved full national coverage with treatment of more than 90% of the school-age population.\\ud\nMethods\\ud\n\\ud\nA cohort of 1727 schoolchildren (6\u201314 years old) was monitored at yearly intervals through a longitudinal survey. Additional groups of schoolchildren were monitored in cross-sectional surveys. Parasitological examinations for Schistosoma haematobium and Schistosoma mansoni were performed, and prevalence and intensity of infection before and after treatment were analysed.\\ud\nFindings\\ud\n\\ud\nData from the longitudinal cohort show that a single round of PZQ treatment significantly reduced prevalence of S. haematobium infection by 87% (from 59.6% to 7.7%) and intensity of infection by 92.8% (from 94.2 to 6.8 eggs\/10 ml of urine) 2 years post-treatment. The impact on infection was also confirmed by a cross-sectional survey 2 years post-treatment. Importantly, the proportion of school-age children with heavy S. haematobium infection decreased from around 25% before treatment to around 2\u20133% 2 years post-treatment. Cross-sectional comparison of S. haematobium infection in 7-year-old children in their first year at school, who received treatment through community-based drug delivery, also showed significant reduction in both prevalence (65.9%) and intensity of S. haematobium infection (78.4%) 2 years after single treatment. A significant reduction in S. mansoni infection was also achieved.\\ud\nConclusion\\ud\n\\ud\nSignificant and sustained reduction in S. haematobium infection was achieved by biennial treatment in school-age children in Burkina Faso. This may provide a cost-effective treatment strategy for similar national schistosomiasis control programmes in sub-Saharan Africa","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"World Health Organization","rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:eprints.lse.ac.uk:37717<\/identifier><datestamp>\n      2012-06-11T09:37:08Z<\/datestamp><setSpec>\n      74797065733D4445505453:4C53452D5354<\/setSpec><\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:relation>\n    \n      \n        http:\/\/eprints.lse.ac.uk\/37717\/<\/dc:relation><dc:title>\n        Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso<\/dc:title><dc:creator>\n        Toure, Seydou<\/dc:creator><dc:creator>\n        Zhang, Y.<\/dc:creator><dc:creator>\n        Bosque-Oliva, Elisa<\/dc:creator><dc:creator>\n        Ky, Cesaire<\/dc:creator><dc:creator>\n        Ouedraogo, Amadou<\/dc:creator><dc:creator>\n        Koukounari, Artemis<\/dc:creator><dc:creator>\n        Gabrielli, Albis F<\/dc:creator><dc:creator>\n        Sellin, Bertrand<\/dc:creator><dc:creator>\n        Webster, Joanne P.<\/dc:creator><dc:creator>\n        Fenwick, Alan<\/dc:creator><dc:subject>\n        DT Africa<\/dc:subject><dc:subject>\n        RA Public aspects of medicine<\/dc:subject><dc:description>\n        Objective\\ud\n\\ud\nTo evaluate the impact on schistosomiasis of biennial treatment with praziquantel (PZQ) among school-age children in Burkina Faso, the first country that achieved full national coverage with treatment of more than 90% of the school-age population.\\ud\nMethods\\ud\n\\ud\nA cohort of 1727 schoolchildren (6\u201314 years old) was monitored at yearly intervals through a longitudinal survey. Additional groups of schoolchildren were monitored in cross-sectional surveys. Parasitological examinations for Schistosoma haematobium and Schistosoma mansoni were performed, and prevalence and intensity of infection before and after treatment were analysed.\\ud\nFindings\\ud\n\\ud\nData from the longitudinal cohort show that a single round of PZQ treatment significantly reduced prevalence of S. haematobium infection by 87% (from 59.6% to 7.7%) and intensity of infection by 92.8% (from 94.2 to 6.8 eggs\/10 ml of urine) 2 years post-treatment. The impact on infection was also confirmed by a cross-sectional survey 2 years post-treatment. Importantly, the proportion of school-age children with heavy S. haematobium infection decreased from around 25% before treatment to around 2\u20133% 2 years post-treatment. Cross-sectional comparison of S. haematobium infection in 7-year-old children in their first year at school, who received treatment through community-based drug delivery, also showed significant reduction in both prevalence (65.9%) and intensity of S. haematobium infection (78.4%) 2 years after single treatment. A significant reduction in S. mansoni infection was also achieved.\\ud\nConclusion\\ud\n\\ud\nSignificant and sustained reduction in S. haematobium infection was achieved by biennial treatment in school-age children in Burkina Faso. This may provide a cost-effective treatment strategy for similar national schistosomiasis control programmes in sub-Saharan Africa.<\/dc:description><dc:publisher>\n        World Health Organization<\/dc:publisher><dc:date>\n        2008-10<\/dc:date><dc:type>\n        Article<\/dc:type><dc:type>\n        PeerReviewed<\/dc:type><dc:identifier>\n          Toure, Seydou and Zhang, Y. and Bosque-Oliva, Elisa and Ky, Cesaire and Ouedraogo, Amadou and Koukounari, Artemis and Gabrielli, Albis F and Sellin, Bertrand and Webster, Joanne P. and Fenwick, Alan  (2008) Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.  Bulletin of the World Health Organization, 86 (10).  pp. 737-816.  ISSN 0042-9686     <\/dc:identifier><dc:relation>\n        http:\/\/www.who.int\/bulletin\/en\/<\/dc:relation><dc:relation>\n        10.2471\/BLT.07.048694<\/dc:relation><\/oai_dc:dc><\/metadata><\/record>","journals":null,"language":null,"relations":["http:\/\/eprints.lse.ac.uk\/37717\/","http:\/\/www.who.int\/bulletin\/en\/","10.2471\/BLT.07.048694"],"year":2008,"topics":["DT Africa","RA Public aspects of medicine"],"subject":["Article","PeerReviewed"],"fullText":null}